Prothena Corporation plc (PRTA)
$8.84+2.67%Close
SELLRECOVERY · day 3
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $463M
- Beta
- -0.33
- P/E (TTM)
- -9.66
- Short % float
- 17.34%
- Days to cover
- 13.8
- SI change
- -6.3%
- 1W
- +5.74%
- 1M
- -2.00%
- vs SPY 1W
- +4.58%
- vs SPY 1M
- -4.99%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on PRTA?
- LOPJLB’s latest quantitative signal on Prothena Corporation plc (PRTA) is SELL in a RECOVERY regime. Signals are updated daily.
- What market regime is PRTA in?
- Prothena Corporation plc (PRTA) is currently classified in the RECOVERY HMM market regime on LOPJLB.
- What does Prothena Corporation plc (PRTA) do?
- Prothena Corporation plc, a late-stage clinical biotechnology company, focuses on discovery and development of novel therapies to treat diseases caused by protein dysregulation. Its product pipeline includes Prasinezumab, an investigational humanized monoclonal antibody which is in Phase 3 clinical trial for the treatment of parkinson's disease and other synucleinopathies. The company also deve…